000516SZSE
🚨 Material Event

Prospectus (Registration Draft)

✨ AI Summary

Xi'an International Medical Investment Co., Ltd. is issuing shares to specific targets for listing on the Main Board. The company faces risks including lower-than-expected utilization rates for its smart elderly care and proton therapy projects, potential profitability challenges due to long payback periods, and ongoing financial losses. This prospectus outlines these material risks, regulatory compliance, and the company's operational outlook to inform investor decision-making.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 000516 Stock Abbreviation: International Medical

Xi'an International Medical Investment Co., Ltd.

(5th Floor, Baozhang Building, No. 16 Tuanjie South Road, High-tech Zone, Xi'an, Shaanxi Province)

Issuance of Shares to Specific Targets and Listing on the Main Board

Prospectus (Registration Draft)

Sponsor (Lead Underwriter)

Guotai Haitong Securities Co., Ltd.

(No. 618 Shangcheng Road, China (Shanghai) Pilot Free Trade Zone)

July 2026

Statement

  1. The company and all members of the Board of Directors guarantee that the contents of this prospectus are true, accurate, and complete, and confirm that there are no false records, misleading statements, or major omissions.

The person in charge of the company, the person in charge of accounting work, and the person in charge of the accounting department guarantee the truthfulness and completeness of the financial and accounting data in this prospectus.

  1. This prospectus is prepared in accordance with the "Administrative Measures for the Registration of Securities Issuance by Listed Companies," the "Information Disclosure Content and Format Guidelines for Companies Offering Securities to the Public No. 61 — Prospectus and Issuance Report for Securities Issued by Listed Companies to Specific Targets," and other requirements.

This prospectus is the Board of Directors' explanation of this issuance of shares to specific targets; any statement to the contrary is a false statement.

  1. Any decision or opinion made by the China Securities Regulatory Commission (CSRC) or the Shenzhen Stock Exchange regarding this issuance does not indicate their guarantee of the truthfulness, accuracy, or completeness of the application documents and disclosed information, nor does it constitute a substantive judgment or guarantee of the issuer's profitability, investment value, or investor returns. Any statement to the contrary is a false statement.

  2. In accordance with the "Securities Law," the issuer is solely responsible for changes in its operations and earnings after the securities are issued according to law. Investors shall independently judge the investment value of the issuer, make their own investment decisions, and bear the investment risks caused by changes in the issuer's operations and earnings or fluctuations in securities prices after the issuance.

  3. If investors have any questions, they should consult their stockbroker, lawyer, professional accountant, or other professional advisor.

  4. The matters stated in this prospectus do not represent a substantive judgment, confirmation, approval, or consent to registration by the approval authorities regarding the matters related to this issuance of shares to specific targets. The effectiveness and completion of the matters related to this issuance of shares to specific targets are subject to the approval or consent to registration by the relevant approval authorities.

Major Matters Notice

The company specifically reminds investors to carefully read the full text of this prospectus before making investment decisions and to pay special attention to the following important matters.

I. The Company Specifically Reminds Investors to Pay Attention to the Following Risks Among Risk Factors

The company requests that investors carefully read the full text of "Section VI: Risk Factors Related to This Issuance" in this prospectus and pay special attention to the following risks:

(I) Risk of Lower-than-Expected Utilization Rates of Fundraising Projects

The smart elderly care project is located in the High-tech Zone of Xi'an, targeting local high-income retirees and individuals with medical needs such as disability or dementia. The project plans for 1,920 operating beds. The company expects occupancy rates for years 1-7 to be 37%, 48%, 62%, 75%, 82%, 89%, and 94% respectively, stabilizing at 95% from the 8th year onwards, which is a high level. According to data from the Shaanxi Provincial Department of Human Resources and Social Security, the base for calculating basic pensions in Shaanxi Province in 2025 was 7,881 yuan/month. Acceptance of this project by the general retired population may be low, and coupled with factors such as industry development and market competition, the actual occupancy rate may not reach the predicted level. If the occupancy rate fails to meet expectations, the asset revitalization effect after the renovation of existing beds will be lower than expected, posing a risk of idle beds.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.